- Published on
R (on the Application of Quintavalle) v Human Fertilisation and Embryology Authority (HFEA) (2003) - Study Notes
Core Issue: Does the HFEA have the power to license pre-implantation genetic diagnosis (PGD) specifically for tissue typing purposes (to create a "savior sibling")?
Facts:
Core Issue: Does the HFEA have the power to license pre-implantation genetic diagnosis (PGD) specifically for tissue typing purposes (to create a "savior sibling")?
Facts:
- The Hashmi Family: Had a child with beta thalassemia major (a severe blood disorder). The best treatment was a bone marrow transplant using stem cells from a matching newborn's umbilical cord.
- The Goal: The Hashmis wanted to use IVF with PGD to select an embryo that was both free from thalassemia and a tissue match for their existing child.
- HFEA's Initial Stance: The HFEA was willing to grant a license, but only if PGD was already needed to avoid passing on a genetically inherited condition.
- Legal Challenge: The HFEA's power to issue a license for PGD for tissue typing was challenged in court.
- Key Questions:
- Is genetic analysis of an embryo cell a "use" of the embryo, requiring a license?
- Does the definition of "treatment services" in the Human Fertilisation and Embryology Act (HFEA) 1990 (specifically, "assisting women to carry children") exclude PGD for tissue typing?
- High Court Decision: Ruled against the HFEA. PGD was a "use" of the embryo requiring a license, and tissue typing fell outside the definition of "treatment services."
- Overturned the High Court decision. The Court of Appeal allowed the appeal, meaning they sided with the HFEA's power to grant the license.
- Reasoning based on Schedule 2, para 1(1)(d) of the HFEA 1990: This allows licenses for treatment "designed to secure that embryos are in a suitable condition to be placed in a woman or to determine whether embryos are suitable for that purpose."
- Key Interpretation of "Suitable": The court stated the meaning of "suitable" depends on the context. If the treatment's purpose is to find a suitable source of stem cells (i.e., a tissue match), then tissue typing is treatment within the meaning of the law.
- Established Precedent: Affirmed the HFEA's power to license PGD for tissue typing, opening the door to creating "savior siblings."
- Focus on "Suitability": The case highlights the importance of interpreting legal terms like "suitable" within the specific context and intended purpose of the treatment.
- Inconsistency in HFEA Decisions: The case mentions a similar situation (the Whitakers) where the HFEA refused a license. This suggests there may be nuances in how the HFEA applies this ruling in practice, or that other factors come into play when deciding whether or not to grant a license.
- Ethical Considerations: This case raises ethical issues related to the creation of "savior siblings" and the potential for instrumentalizing children. (This is implied, not explicitly stated in the provided text). """
0 Comments